US BANCORP \DE\ - SAGENT PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$71,000
+39.2%
4,757
+12.8%
0.00%
Q1 2016$51,000
-22.7%
4,218
+1.7%
0.00%
Q4 2015$66,000
+175.0%
4,146
+169.6%
0.00%
Q3 2015$24,0001,5380.00%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Timpani Capital Management LLC 110,215$2,248,0001.32%
Healthcare Value Capital, LLC 73,822$1,506,0001.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,014,863$20,703,0000.96%
Perimeter Capital Partners, LLC 248,893$5,077,0000.94%
Tekla Capital Management LLC 270,031$5,509,0000.61%
SECTORAL ASSET MANAGEMENT INC 564,325$11,512,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 168,268$3,432,0000.35%
MENTA CAPITAL LLC 30,480$622,0000.32%
KOPP INVESTMENT ADVISORS LLC 39,934$815,0000.30%
Broadfin Capital, LLC 68,300$1,393,0000.25%
View complete list of SAGENT PHARMACEUTICALS INC shareholders